A breast biopsy is a simple medical procedure in which a sample of breast tissue is removed and sent to a laboratory for testing. The procedure is less invasive than surgical biopsy, leaves little or no scarring and can be performed in less than an hour. According to Our Company, global breast biopsy market is projected to grow at a CAGR of 5.5% during the forecast period 2020-2026.

The report offers a breakdown of market shares by product, including Vacuum-Assisted Biopsy (VAB), Core-Needle Biopsy (CNB), Fine-Needle Aspiration Biopsy (FNAB). Based on end use, the market for breast biopsy is segmented into Diagnostic Centers, Hospitals. By technology, the breast biopsy market is classified into MRI-Guided Biopsy, Ultrasound-Guided Biopsy, Mammography-Guided Stereotactic Biopsy, CT-Guided Biopsy. On the basis of region, the breast biopsy industry is analyzed across North America, Europe, Asia-Pacific, South America and MEA (the Middle East, and Africa).

By Product:
Vacuum-Assisted Biopsy (VAB)
Core-Needle Biopsy (CNB)
Fine-Needle Aspiration Biopsy (FNAB)

By End Use:
Diagnostic Centers
Hospitals

By Technology:
MRI-Guided Biopsy
Ultrasound-Guided Biopsy
Mammography-Guided Stereotactic Biopsy
CT-Guided Biopsy

By region, the market is analyzed across North America, Asia Pacific, Europe, Middle East & Africa and South America. This report forecasts revenue growth at global, regional & country level from 2020 to 2026.
North America (U.S., Canada, Mexico, etc.)
Asia-Pacific (China, Japan, India, Korea, Australia, Indonesia, Taiwan, Thailand, etc.)
Europe (Germany, UK, France, Italy, Russia, Spain, etc.)
Middle East & Africa (Turkey, Saudi Arabia, Iran, Egypt, Nigeria, UAE, Israel, South Africa, etc.)
South America (Brazil, Argentina, Colombia, Chile, Venezuela, Peru, etc.)

The market research report covers the analysis of key stake holders of the breast biopsy market. Some of the leading players profiled in the report include:
Argon Medical Devices, Inc.
Becton and Dickinson Company
C. R. Bard, Inc.
Cook Medical Incorporated
Danaher Corporation (Leica Biosystems)
Encapsule Medical Devices, LLC
Ethicon Inc.
Hologic Inc.
Intact Medical Corporation
*list is not exhaustive, request free sample to get a complete list of companies

The base year of the study is 2019, and forecasts run up to 2026.

Research Objective
To analyze and forecast the market size of global breast biopsy market.
To classify and forecast global breast biopsy market based on product, end use, technology.
To identify drivers and challenges for global breast biopsy market.
To examine competitive developments such as mergers & acquisitions, agreements, collaborations and partnerships, etc., in global breast biopsy market.
To conduct pricing analysis for global breast biopsy market.
To identify and analyze the profile of leading players operating in global breast biopsy market.

The report is useful in providing answers to several critical questions that are important for the industry stakeholders such as manufacturers and partners, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities. Key target audience are:
Manufacturers of breast biopsy
Raw material suppliers
Market research and consulting firms
Government bodies such as regulating authorities and policy makers
Organizations, forums and alliances related to breast biopsy